Novità nelle cure
Ipertermia ed immunoterapia ottengono una risposta completa in tre casi resistenti a tutte le terapie
La combinazione di ipertermia ed immunoterapia nei pazienti oncologici sembra assai promettente. In questo studio si è ottenuta una risposta completa in tre casi resistenti alle terapie tradizionali o alla sola immunoterapia.
Gan To Kagaku Ryoho. 2011 Nov;38(12):1939-41.
[Hyperthermic Immunotherapy Was Effective in 3 CR Cases as the Standard Treatments Had No Effects or Could Not Be Enforced].
[Article in Japanese]
Osaka Cancer Immuno- Chemotherapy Center.
We treated 1, 225 advanced or recurrent cancer patients with hyperthermia or immunotherapy (2005/7-2010/12). We had 174( 14.7%)clinical benefit cases( CR, PR and long SD) including 32 complete response( CR) cases. Case 1: A 63-year-old male, rectal cancer, post operative recurrence with MRSA abscess located in abdomen. He was treated with dendritic cell therapy and hyperthermia. He showed a CR. Case 2: A 62-year-old female, ovarian cancer, post operative recurrence. She was treated with standard chemotherapy, but she showed a PD. Then she was treated with dendritic cell therapy and hyperthermia. She showed a CR. Case 3: A 46-year-old female, lung cancer, postoperative recurrence. She was treated with standard chemotherapy and molecular target therapy, but she showed a PD. Then she was treated with dendritic cell therapy and hyperthermia. She showed a CR.